C4 Therapeutics Inc (CCCC) — Capital Reinvestment Ratio
C4 Therapeutics Inc (CCCC) has a Capital Reinvestment Ratio of 0.02x as of June 2019, meaning it reinvests 0% of its operating cash flow ($36.91 Million) in capital expenditures ($641.00K). Check how tangible is C4 Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
C4 Therapeutics Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks C4 Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see C4 Therapeutics Inc cash conversion from operations.
Annual Capital Reinvestment Ratio for C4 Therapeutics Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for C4 Therapeutics Inc from 2019 to 2019. See C4 Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.02x | $55.61 Million | $1.35 Million | — |